News
Get the latest from AFT 27 三月 2020 - 00:00:00
28 八月 2017 - 00:00:00
AFT Launches PALLAS Trial Alliance Foundation Trials and Austrian Breast & Colorectal Cancer Study Group Open Largest Global Phase 3 Trial of Targeted Therapy, IBRANCE® (palbociclib), for Patients with Hormone Receptor-Positive Early Breast Cancer Read more
01 六月 2017 - 00:00:00